Rubinstein-Taybi syndrome (RTS) is a rare genetic condition characterized by broad thumbs and big toes, distinctive facial features, short stature, and moderate-to-severe intellectual disability. It affects roughly 1 in 100,000 to 125,000 newborns, and about 99% of cases arise from a new (de novo) mutation, meaning the child is typically the first person in the family to have the condition.
Genetic Cause
RTS is caused by changes in genes that help regulate how other genes are turned on and off during development. Two genes are involved. The first, called CREBBP, accounts for 50% to 60% of cases and is classified as type 1 RTS. The second gene, EP300, accounts for 8% to 11% of cases and is classified as type 2. In roughly 30% of people with RTS, no mutation in either gene can be identified with current testing methods.
The condition follows an autosomal dominant pattern, meaning a single altered copy of the gene is enough to cause it. Despite that inheritance pattern, almost all cases are sporadic. The mutation happens for the first time in the affected child rather than being passed down from a parent. A small number of familial cases have been reported, including situations where a mildly affected parent carried the mutation in only some of their cells (a phenomenon called somatic mosaicism), which helps explain why the syndrome can look so different from one person to the next.
Physical Features
The most recognizable physical hallmark is unusually broad, often angled thumbs and big toes. Skeletal abnormalities, primarily these thumb and toe differences, appear in about 92% of people with the syndrome. The thumbs may be widened and bend outward at the tip, and the big toes tend to look similarly broad and flat.
Facial features become more distinctive over time. They commonly include arched or thick eyebrows, downward-slanting eyes, a prominent nose with a beak-like shape where the base of the nose extends below the nostrils, low-set ears, a high-arched palate, a slightly small chin, and crowded or misaligned teeth. Many people with RTS also have a characteristic smile sometimes described as a “grimace,” where the eyes close nearly all the way.
Growth Patterns
Babies with RTS are usually born at a normal weight and length. Growth slows during infancy and childhood, and adults tend to be significantly shorter than average. A study of 92 individuals with molecularly confirmed RTS found that average adult height was about 163 cm (5’4″) for males and 151 cm (4’11”) for females, placing both roughly three standard deviations below the general population mean. Head circumference also tends to be smaller than average.
Syndrome-specific growth charts have been developed so that clinicians can track a child’s growth against others with the same condition rather than the general population. This helps distinguish expected RTS growth patterns from separate medical problems that might also be affecting growth. Weight tends to be proportionate in males, but females with RTS may have a higher body mass index compared to the general population.
Intellectual and Behavioral Development
Most people with RTS have moderate-to-severe intellectual disability, though the range varies. Children typically reach developmental milestones like sitting, walking, and speaking later than their peers. Speech and language development is often particularly delayed, and many children benefit from early speech therapy and alternative communication strategies.
Behaviorally, people with RTS are often described as friendly and sociable. Some may have attention difficulties, repetitive behaviors, or mood changes, and these can shift at different stages of life. Early intervention services, including occupational therapy, physical therapy, and speech therapy, can make a meaningful difference in daily functioning and quality of life.
Tumor Risk
Because the genes involved in RTS help control cell growth and gene regulation, there has been longstanding interest in whether the syndrome raises cancer risk. A nationwide Dutch study found that certain benign (noncancerous) tumors do occur more often. Pilomatricomas, which are small, hard lumps under the skin that arise from hair follicle cells, were found in about 17% of molecularly confirmed RTS patients compared to 0.16% in the general population. Meningiomas, benign tumors of the tissue surrounding the brain, occurred in about 8% of confirmed cases versus less than 0.1% in the general population.
The picture for malignant (cancerous) tumors is less clear. A small number of cancers have been reported in people with RTS, including brain tumors, lymphoma, and breast and colon cancers, but there is not yet strong statistical evidence that the overall cancer risk is higher than in the general population. The rarity of the syndrome makes it hard to draw firm conclusions, so awareness of unusual lumps or new symptoms remains worthwhile.
How RTS Is Diagnosed
Diagnosis usually begins with a clinical evaluation. A doctor or geneticist recognizes the combination of broad thumbs and toes, characteristic facial features, short stature, and developmental delay. No single feature is enough on its own, but the pattern together is distinctive, especially as the child grows older and facial features become more pronounced.
Genetic testing can confirm the diagnosis by identifying a mutation in the CREBBP or EP300 gene. This confirmation is helpful for guiding medical management and for family planning discussions, but since about 30% of clinically diagnosed individuals do not have a detectable mutation in either known gene, a negative genetic test does not rule the syndrome out if the clinical picture is strong.
Long-Term Management
There is no cure for RTS, and care focuses on managing the various physical and developmental challenges through a coordinated team approach. The first international consensus statement on RTS management, published in 2024, laid out recommendations covering everything from heart and kidney screening in childhood to behavioral support and dental care throughout life.
In practical terms, children with RTS typically need regular monitoring by several specialists. Eye exams, hearing tests, heart evaluations, and kidney imaging are commonly recommended in early life to catch problems that may not cause obvious symptoms. Dental care is important because of the high rate of crowding and alignment issues. Orthopedic follow-up may be needed if thumb or toe differences affect hand function or walking.
Developmental support is just as important as medical monitoring. Early intervention programs that combine physical, occupational, and speech therapy can help children build skills and independence. Educational plans tailored to the child’s abilities, often in a supportive classroom setting, allow many individuals with RTS to participate actively in school and community life. Adults with RTS generally continue to need some level of daily support, but many develop meaningful social connections and enjoy a good quality of life with the right accommodations in place.

